SLC6A3 and Alzheimer disease: SPECT imaging using the dopamine transporter (DAT) ligand [123I]FP-CIT is widely used to aid the etiological diagnosis of uncertain parkinsonian syndromes and to distinguish dementia with Lewy bodies from Alzheimer’s disease [1–5].